telaprevir


Also found in: Medical, Wikipedia.
Related to telaprevir: sofosbuvir
Translations

telaprevir

n telaprevir m
References in periodicals archive ?
Second, approximately 25% of telaprevir reactions occur within 4 days of starting the drug, and 46% occur after 4 weeks.
Drug therapies (lamivudine, entecavir, adefovir, tenofovir, telaprevir, boceprevir, Viread, Myozyme, darbepoetin, symeprewir).
Telaprevir is an oral DAA protease inhibitor (PI) approved for treatment-naive and treatment-experienced patients with HCV genotype 1 infection.
In 2011, NYDOCCS piloted a hepatitis C treatment program for HCV genotypes 1a and 1b, comprised of telaprevir, pegylated interferon, and ribavirin.
Daklinza's approval is supported by data from the company's open-label, randomized study of Daklinza with sofosbuvir in genotypes 1, 2, and 3, including patients with no response to prior therapy with telaprevir or boceprevir and patients with fibrosis.
A new standard of care has emerged with the regulatory approval of the protease inhibitors boceprevir and telaprevir.
Health Care System, looked at 859 patients registered with the VA's Clinical Case Registry for HCV who initiated triple therapy with pegylated interferon, ribavirin, and either boceprevir (n = 661) or telaprevir (n = 198) before Jan.
John's wort to BPCS immediately, citing what it says are deaths from drug interactions; its "dangerous" interaction with prescription drugs; and FDA's SJVV label warnings for two new Hepatitis C virus products, Boceprevir and Telaprevir.
Telaprevir, a drug approved for use against hepatitis C, inhibits replication of the virus.
This edition includes new drugs, including Azilsartan Medoxomil, Boceprevir, Clobazam, Ezogabine, Fidaxomicin, Linagliptin, Rilpivirine, Rivaroxaban, Telaprevir, Roflumilast, Ticagrelor, and Vilazodone; updated bisphosphonate, antipsychotic, carbapenem, and proton pump inhibitor group monographs; new combinations such as Emtricitabine/Rilpivirine/Tenofovir; and a revised ophthalmic/otic chapter with additions like glaucoma combinations, mast cell stabilizers, ophthalmic antihistamines, and otic corticosteroids.
telaprevir (Incivek, Vertex Pharmaceuticals), an HCV genotype-1 protease inhibitor, combined with peginterferon alfa-2a (Pegasys, Genetech) plus ribavirin (Copegus, Genetech; Rebetol, Merck; etc.
The warning comes ahead of the roll-out of two new drugs - Telaprevir and Boceprevir - later this year that will help tackle the virus.